Logo del repository
  1. Home
 
Opzioni

Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy

Bonifacio M.
•
Scaffidi L.
•
Binotto G.
altro
Tiribelli M.
2018
  • journal article

Periodico
LEUKEMIA RESEARCH
DOI
10.1016/j.leukres.2018.09.018
WOS
WOS:000449112000012
Archivio
http://hdl.handle.net/11390/1139361
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85054425060
www.elsevier.com/locate/leukres
Diritti
metadata only access
Soggetti
  • Adverse event

  • Branded imatinib

  • Generic imatinib

  • Molecular response

  • Saving

  • Hematology

  • Oncology

  • Cancer Research

Scopus© citazioni
8
Data di acquisizione
Jun 2, 2022
Vedi dettagli
Web of Science© citazioni
9
Data di acquisizione
Mar 19, 2024
Visualizzazioni
4
Data di acquisizione
Apr 19, 2024
Vedi dettagli
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback